Podcast
The Vox Markets Podcast
Hosted by Vox Markets Podcast · EN
Vox Markets is revolutionising the way companies engage with all classes of shareholders. Listen here to interviews with company executives and sell-side analysts and fund managers discuss their investment insights.
100episodes
Episodes
Newest firstAll episodes
2413: Is EGT now set for revenues of £50m?
4d ago00:11:52Tap to summarizeWatch on YouTubeEuropean Green Transition's founder and executive chairman Cathal Friel joins Vox to talk about the company's latest set of financial results - for the full year to December 2025 - and to lay out his vision for where EGT goes next. Last year was about building a foundation on which to conduct significant M&A, and in 2026 EGT has duly delivered on that vision. It has acquired a major wind services business operating in Ireland and the UK, and Friel is optimistic that revenues can go to £50 million in the medium term. EGT is already moving away from the start-up phase, and is now in a period of sustained consolidation and growth.
Transcribe →2412: RentGuarantor Revenues Surge 155%
4d ago00:10:34Tap to summarizeWatch on YoutubeRentGuarantor has reported a sharp acceleration in trading, including record May revenue, strong contract growth and its first positive monthly EBITDA since AIM admission. In this interview, CEO Paul Foy discusses whether the Renters’ Rights Act has created a structural demand shift, how the new damage-cover offering changes the model, and whether AI can help the company scale profitably without weakening risk controls.
Transcribe →2411: Poolbeg Pharma: What US Payers Really Said
4d ago00:14:41Tap to summarizeWatch on YouTubeIndependent US payer research commissioned by Poolbeg Pharma shows strong commercial backing for POLB 001 — a first-in-class preventative for cancer immunotherapy-induced CRS. Chris from Acumentis Global on what payers said, and what it means for the commercial opportunity ahead.
Transcribe →2410: Great Southern Copper targets district-scale porphyry system in Chile
5d ago00:23:59Tap to summarizeWatch on YouTubeGreat Southern Copper has just initiated a new of drilling on its Chilean portfolio of assets, targeting the Victoria prospect on the wider Especularito project. Recent drilling undertaken by Great Southern nearby to Victoria has confirmed the presence of a copper-porphyry-style alteration system and the wider area is highly prospective as a district-scale play. Great Southern's chief executive Sam Garrett joins Vox to tell us what success would look like, and where the company goes from here.
Transcribe →2409: Prospex Energy: The Bases Are Loaded as Asset Momentum Builds into 2027
6d ago00:09:48Tap to summarizeWatch on YouTubeProspex Energy’s 2025 annual report points to a year of investment, repair and repositioning across its European gas portfolio. With Selva producing, Viura back online, Tarba now wholly owned, and new licences awarded in Poland, the company says momentum is building. In this interview, CEO Tom Reynolds discusses Prospex’s funding position, the next steps for key assets, and the milestones investors should watch over the next 12 to 18 months.#PXEN #Energy #Gas
Transcribe →
2408: MedPal Hits Record Prescription Volumes & £5m Run-Rate
6d ago00:05:47Tap to summarizeMedPal AI has reported its strongest month since launch, with more than 42,250 prescription items dispensed in May and cumulative volumes now above 250,000. In this interview, CEO Jason Drummond discusses what is driving the growth, whether 34% pharmacy gross margins are sustainable, and how investors should judge the path from operational momentum to cash generation.
Transcribe →2407: Blencowe boosts Orom-Cross with updated DFS
1w ago00:07:49Tap to summarizeWatch on YouTubeBlencowe Resources has released an updated definitive feasibility study for its Orom-Cross graphite project in Uganda. The new study has boosted net present value by 15% to US$1.24 billion, and increased the projected cashflow over the life of the mine by 100% to over US$4 billion. These are big numbers, especially considering that the capex number remains the same. Meanwhile, the company is continuing funding talks with renewed confidence. Mike Ralston, Blencowe's chief executive tells Vox all about it
Transcribe →2406: 2 P's on a Pod: What’s Next in UK M&A?
1w ago01:22:11Tap to summarizeWatch on YouTubeIn this week’s live smallcap show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 19 stock ideas.00:00 View on markets and recent buys & sells03:30 Beeks Financial06:00 Invinity Energy Systems09:45 Bodycote13:30 Advanced Medical Solutions21:20 Gamma Communications25:40 PPHE Hotels28:50 Aptitude Software34:20 Capita38:15 CT Automotive44:35 Hollywood Bowl48:45 Tortilla Mexican51:30 Hardide56:05 Zotefoams59:40 WISE1:04:20 Pebble Beach Systems1:08:15 LSL Property1:10:25 Softcat1:13:20 XP Factory1:16:10 Calnex Solutions#BKS #IES #BOY #AMS #GAMA #PPH #APTD #CPI #CTA #BOWL #MEX #HDD #ZTF #WISE #PEB #LSL #SCT #XPF #CLX
Transcribe →2405: ACG Metals set for US$200m EBITDA next year
1w ago00:16:19Tap to summarizeWatch on YouTubeACG Metals is just about finished with construction of the copper production line at its Turkish mine. This will add significant cashflow to a project that is already up and running and producing gold. ACG's chairman Artem Volynets says that in the 2027-2028 financial year EBITDA should hit US$200 million. Once the company refinances its bonds it will then be in a position to start paying dividends. It will also look upwards and outwards, and start to seek acquisitions in Europe and Central Asia.#ACG #Mining #Copper
Transcribe →2404: MedPal AI Launches New Health — £1.3m Push Into GLP-1
2w ago00:12:00Tap to summarizeMedPal AI (AIM: MPAL) launches New Health, a standalone GLP-1 sub-brand backed by £1.3 million of marketing, ahead of expected UK approval of Novo Nordisk’s oral Wegovy. CEO Jason Drummond on the strategy, the market, and the unit economics behind it.
Transcribe →